MS: Busting the Myths
May 29, 2025 | News
Multiple Sclerosis New Zealand, Multiple Sclerosis Auckland, the New Zealand Multiple Sclerosis Research Trust, and Rare Disorders NZ supported research conducted by COMPASS Research Centre that leveraged the Stats NZ Integrated Data Infrastructure (IDI) to research MS epidemiology. This research […]
May 24, 2022 | Research
ABX-002, an experimental treatment for multiple sclerosis (MS) being developed by Autobahn Therapeutics, promoted the restoration of the myelin sheath in preclinical models of the disease, new data show. The research, which specifically tested an analog of ABX-002 called LL-341070, will be presented […]